ESTADO ACTUAL DEL TRASPLANTE RENAL EN CHILE A 58 AÑOS DEL PRIMERO; “MI VISIÓN”

This article reviews the evolution of kidney transplantation in Chile, beginning with the first successful transplant in 1966 at the University of Chile. It highlights the establishment of kidney transplant programs that predominantly used living donors between 1968 and 1994, culminating in the first combined pancreas-kidney transplant in 1994. The article reviews the historical progression of immunosuppressive therapies, detailing the switch from steroids and azathioprine to cyclosporine, which improved graft survival. Advances in immunologic moni- toring, including the Terasaki crossmatch test and the Luminex procedure, have facilitated early diagnosis of rejection. The new immunosuppressants, Tacrolimus, Rituximab, and Belatacept, which have improved prevention and management of rejection, are discussed. Graft survival rates in Chile are comparable to those in the USA, but problems related to donor recruitment and post-transplant care persist. Finally, emerging alternatives such as xenotransplantation and tissue bioengineering are explored, with challenges to overcome before their clinical application.

Authors

Institutions

Publication Details

Journal
Boletín :
Published
2025-03-05
DOI
https://doi.org/10.69700/rg3r1206
Primary Topic
Ethics and bioethics in healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ESTADO ACTUAL DEL TRASPLANTE RENAL EN CHILE A 58 AÑOS DEL PRIMERO; “MI VISIÓN”

JORGE MORALES BARRÍA
Boletín :
Ethics and bioethics in healthcare
article

ESTADO ACTUAL DEL TRASPLANTE RENAL EN CHILE A 58 AÑOS DEL PRIMERO; “MI VISIÓN”

JORGE MORALES BARRÍA
article en

Abstract

This article reviews the evolution of kidney transplantation in Chile, beginning with the first successful transplant in 1966 at the University of Chile. It highlights the establishment of kidney transplant programs that predominantly used living donors between 1968 and 1994, culminating in the first combined pancreas-kidney transplant in 1994. The article reviews the historical progression of immunosuppressive therapies, detailing the switch from steroids and azathioprine to cyclosporine, which improved graft survival. Advances in immunologic moni- toring, including the Terasaki crossmatch test and the Luminex procedure, have facilitated early diagnosis of rejection. The new immunosuppressants, Tacrolimus, Rituximab, and Belatacept, which have improved prevention and management of rejection, are discussed. Graft survival rates in Chile are comparable to those in the USA, but problems related to donor recruitment and post-transplant care persist. Finally, emerging alternatives such as xenotransplantation and tissue bioengineering are explored, with challenges to overcome before their clinical application.

Boletín :Vol. 61(LXI)
Universidad de Los Andes, Chile (CL)
Openalex Percentile: Top 94%
Ethics and bioethics in healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.